Inventor · disambiguated record
Jerry Jialun Meng
Also filed as: MENG JERRY J · MENG JERRY JIALUN
6 granted patents·6 pending applications·184 citations·filing 2001–2014
85Inventor score
Technology areasA61P
Top patents by PatentIndex Score
12 records- 0194US7858643B2Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Granted Dec 28, 2010·28 cites·2 claims
- 0293US8106197B2Aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2006·Granted Jan 31, 2012·48 cites·11 claims
- 0392US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 0482US8785632B2Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2012·Granted Jul 22, 2014·5 cites·4 claims
- 0582US6964957B2Fused pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activityAGOURON PHARMA·Filed 2001·Granted Nov 15, 2005·30 cites·49 claims
- 0660US2014288086A1Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2014·Application pending·0 cites
- 0752US2010324061A1Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2010·Application pending·0 cites
- 0847US2010093696A12-amino pyrimidine compoundsPFIZER·Filed 2008·Application pending·0 cites
- 0945US8080556B22-amino pyrimidine compounds as potent HSP-90 inhibitorsKUNG PEI-PEI·Filed 2009·Granted Dec 20, 2011·0 cites·16 claims
- 1042US2006178374A1Aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 1142US2006128724A1Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 1235US2004043959A1Combination therapies for treating methylthioadenosine phosphorylase deficient cellsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →